"At least one indicator used to monitor COVID-19 activity is increasing in all ten HHS regions and many regions are reporting increases in multiple indicators.
▸ The percentages of specimens testing positive for SARS-CoV-2 increased in all ten HHS regions.
▸ The highest percentages of specimens testing positive for SARS-CoV-2 were seen in four regions, mainly the central portion of the U.S. Region: 5 (Midwest at 12.3%), 6 (South Central at 11.7%), 7 (Central at 17.6%) and 10 (Mountain at 12%).
▸ The percentages of visits for ILI (Influenza-like Illness), CLI (COVID-like Illness) or both, increased in five of ten regions.
▸ For some indicators and regions, the increases have been small from week to week but have continued over several weeks while other indicators have increased more sharply in some regions."
Week 44 testing: Week 43 testing:
2,890,895 specimens 2,646,697 specimens
238,214 (8.2%) were positive 187,480 (7.2%) were positive
Week 41 testing: Week 40 testing:
2,632,222 specimens 2,014,912 specimens
141,317 (5.4%) were positive 98,338 (4.9%) were positive
U.S. Cases
Confirmed cases for COVID-19 in the U.S. = 9,913,553 as of November 9, 2020 according to CDC data.
Deaths, in the U.S., coded to ICD-10 diagnosis code,
U07.1, COVID-19 = 237,037 as of November 9, 2020 according to CDC data.
Global Cases
Confirmed cases for COVID-19, globally, according to WHO data = 50,676,072 as of November 10, 2020.
Deaths, globally, according to WHO data = 1,261,075 deaths as of November 10, 2020.
Comments